- Home
- CUE vs MPAA Comparison
CUE vs MPAA Comparison
Compare CUE & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | MPAA |
|---|---|---|
| Founded | 2014 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 202.6M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CUE | MPAA |
|---|---|---|
| Price | $27.77 | $10.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $88.00 | $18.00 |
| AVG Volume (30 Days) | ★ 373.8K | 105.6K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.11 | ★ 162.63 |
| EPS | N/A | ★ N/A |
| Revenue | $27,466,000.00 | ★ $789,806,000.00 |
| Revenue This Year | N/A | $0.60 |
| Revenue Next Year | N/A | $4.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 195.75 | 4.28 |
| 52 Week Low | $0.17 | $9.29 |
| 52 Week High | $45.50 | $18.12 |
Technical Indicators
Market Signals| Indicator | CUE | MPAA |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 38.55 |
| Support Level | $24.27 | $9.99 |
| Resistance Level | $33.11 | $10.95 |
| Average True Range (ATR) | 3.36 | 0.32 |
| MACD | -0.54 | 0.07 |
| Stochastic Oscillator | 43.15 | 45.18 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.